Filing Details
- Accession Number:
- 0001209191-23-045087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-08 19:10:21
- Reporting Period:
- 2023-08-04
- Accepted Time:
- 2023-08-08 19:10:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1324015 | William Jeffrey Henderson | C/O Fibrogen, Inc. 409 Illinois Street San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-08-04 | 2,000 | $1.91 | 30,866 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023.
- Price reported is a weighted-average sales price. The shares were sold at prices ranging from $1.865 to $1.925. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.